Clinical trial
Determination of the Sensitivity of Low-dose Molecular Breast Imaging for the Detection of Small Breast Lesions
NCT01285440 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determination of the Sensitivity of Low-dose Molecular Breast Imaging for the Detection of Small Breast Lesions
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2010
- Completion date
- December 1, 2016
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
suspicious breast lesion for which biopsy is scheduled